Nerve Conduits by Biomaterials held the largest share in the Taiwan Nerve Repair and Regeneration Market -6Wresearch
In 2024, nerve conduits held the largest share in Taiwan’s nerve repair and regeneration market by biomaterials, driven by their crucial role in facilitating nerve regeneration following peripheral nerve injuries. The growth of this segment is supported by Taiwan’s advancements in biomaterials technology, along with increasing demand for effective solutions in treating traumatic nerve damage
According to 6Wresearch, the Taiwan Nerve Repair and Regeneration Market size is projected to grow at a CAGR of 8.6% during 2025-31F. Taiwan’s nerve repair and regeneration market has been experiencing growth, driven by strategic national initiatives and a supportive regulatory environment. A key driver is the government’s Innovative Industries Plan, which channels national resources, funding, and policy support into the biomedical sector. This initiative has fostered a robust ecosystem that promotes research and development, clinical translation, and commercialization of advanced neuroregenerative technologies.
Moreover, the nation’s amendment of the Regulations Governing the Administration or Use of Specific Medical Technology-based Testing or Laboratory Medical Instruments in 2021 removed restrictions on cell therapy and autologous bone marrow mesenchymal stem cell (MSC) transplantation, serving as a major catalyst for the growth of its nerve repair and regeneration market. By easing regulatory barriers, the government has enabled faster clinical application and broader commercialization of regenerative therapies that are essential in repairing damaged nerves and restoring neural function.
Furthermore, Taiwan's demographic shift toward a super-aged society by 2025, when some of the population will be aged older ,is amplifying the demand for neuroregenerative solutions. Dementia, particularly Alzheimer’s disease, poses a growing public health challenge. According to the National Health Research Institutes (NHRI), Taiwanese individuals who are of old age, currently live with dementia, with cases attributed to Alzheimer’s disease.
Additionally, projections indicate that by 2041, the prevalence of dementia among the elderly will approach one in every ten elderly individuals. This aging trend underscores the urgent need for effective nerve repair and regeneration therapies, further driving market growth in Taiwan.
According to Sumit, Senior Research Analyst at 6Wresearch, neurostimulation therapies dominated the Taiwan nerve repair and regeneration market due to the rising prevalence of chronic pain, movement disorders, and epilepsy, coupled with advanced device adoption, improved reimbursement policies, and increasing availability of specialized neurosurgical expertise across major hospitals.
The Taiwan Nerve Repair and Regeneration Market (2025-2031) report provides an in-depth analysis with 26 figures and 8 tables, covered in 76 pages. The report thoroughly covers market type, biomaterials, application, and end-user. The Taiwan Nerve Repair and Regeneration Market outlook report provides an unbiased and detailed analysis of the ongoing Taiwan Nerve Repair and Regeneration Market trends, opportunities/high growth areas, and market drivers, which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
Email Us: sales@6wresearch.com
Call Now: +91-11-430-24-305